The presence of diffuse immune infiltrates including CD8+, Tregs, natural killer (NK) cells, B cells, and in HPV-related HNSCC suggest that checkpoint inhibitors may be beneficial for these patients [1, 2]. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.